GSK’s mRNA flu vaccine advances to Phase III amid cardiovascular and cancer breakthrough insights at DDW

GSK’s mRNA seasonal flu candidate progresses to late-stage trials, while new cardiovascular and cancer research highlight emerging trends and strategies at the latest DDW round-up ahead of the Drug Discovery Innovators & Investors Digital Forum. DDW’s latest weekly round-up points…













